ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection.
Bazzone LE, Zhu J, King M, Liu G, Guo Z, MacKay CR, Kyawe PP, Qaisar N, Rojas-Quintero J, Owen CA, et al. Nat Commun. 2024 May 16; 15(1):4153. Epub 2024 May 16.